2259 related articles for article (PubMed ID: 24145307)
1. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
2. Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats.
Shen CL; Zhu W; Gao W; Wang S; Chen L; Chyu MC
Nutr Res; 2013 Aug; 33(8):668-76. PubMed ID: 23890357
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
4. Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy.
Murakami H; Nakamura T; Tsurukami H; Abe M; Barbier A; Suzuki K
J Bone Miner Res; 1994 Sep; 9(9):1355-64. PubMed ID: 7529459
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
Xu D; Yang W; Zhou C; Liu Y; Xu B
Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
[TBL] [Abstract][Full Text] [Related]
6. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.
Shalhoub V; Shatzen EM; Ward SC; Davis J; Stevens J; Bi V; Renshaw L; Hawkins N; Wang W; Chen C; Tsai MM; Cattley RC; Wronski TJ; Xia X; Li X; Henley C; Eschenberg M; Richards WG
J Clin Invest; 2012 Jul; 122(7):2543-53. PubMed ID: 22728934
[TBL] [Abstract][Full Text] [Related]
7. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
[TBL] [Abstract][Full Text] [Related]
8. [Different Types of Low-frequency Electromagnetic Fields Resist Bone Loss Caused by Weightlessness].
Li WY; Tian YH; Gao YH; Zhu BY; Xi HR; Chen KM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Feb; 41(1):11-20. PubMed ID: 30837037
[TBL] [Abstract][Full Text] [Related]
9. Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency.
Miller MA; Chin J; Miller SC; Fox J
Bone; 1998 Sep; 23(3):257-66. PubMed ID: 9737348
[TBL] [Abstract][Full Text] [Related]
10. Relationship between aortic mineral elements and osteodystrophy in mice with chronic kidney disease.
Matsumoto T; Fukushima S; Kanasaki T; Hagino S
Biol Trace Elem Res; 2012 Dec; 150(1-3):278-84. PubMed ID: 22700181
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid suppression therapy normalizes chronic kidney disease-induced elevations in cortical bone vascular perfusion: a pilot study.
Aref MW; Swallow EA; Metzger CE; Chen N; Moe SM; Allen MR
Osteoporos Int; 2019 Aug; 30(8):1693-1698. PubMed ID: 31069439
[TBL] [Abstract][Full Text] [Related]
12. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
13. Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.
Malluche HH; Monier-Faugere MC; Blomquist G; Davenport DL
Osteoporos Int; 2018 Jan; 29(1):125-134. PubMed ID: 28993865
[TBL] [Abstract][Full Text] [Related]
14. Mineral bone disorders in chronic kidney disease.
Hou YC; Lu CL; Lu KC
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():88-94. PubMed ID: 30298663
[TBL] [Abstract][Full Text] [Related]
15. Effect of sevelamer hydrochloride on bone in experimental uremic rats.
Kuwahara M; Inoshita S; Terada Y; Sasaki S
Ther Apher Dial; 2009 Feb; 13(1):42-8. PubMed ID: 19379169
[TBL] [Abstract][Full Text] [Related]
16. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
[TBL] [Abstract][Full Text] [Related]
17. High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease.
Lau WL; Linnes M; Chu EY; Foster BL; Bartley BA; Somerman MJ; Giachelli CM
Nephrol Dial Transplant; 2013 Jan; 28(1):62-9. PubMed ID: 23045434
[TBL] [Abstract][Full Text] [Related]
18. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
19. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
[TBL] [Abstract][Full Text] [Related]
20. The interplay between bone and vessels in pediatric CKD: lessons from a single-center study.
Preka E; Ranchin B; Doyon A; Vierge M; Ginhoux T; Kassai B; Bacchetta J
Pediatr Nephrol; 2018 Sep; 33(9):1565-1575. PubMed ID: 29872964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]